Metronomic chemotherapy for advanced pleomorphic adenocarcinoma of the nasopharynx
Acta Otorrinolaringol Esp. 2016 May-Jun;67(3):182-4.
doi: 10.1016/j.otorri.2014.09.011.
Epub 2015 Apr 9.
[Article in
English,
Spanish]
Affiliations
- 1 Departamento de Otorrinolaringología, Hospital Clínico i Provincial de Barcelona, Universidad de Barcelona, Barcelona, España. Electronic address: [email protected].
- 2 Departamento de Oncología, Hospital Clínico i Provincial de Barcelona, Universidad de Barcelona, Barcelona, España.
- 3 Departamento de Otorrinolaringología, Hospital Clínico i Provincial de Barcelona, Universidad de Barcelona, Barcelona, España; Departamento de Oncología, Hospital Clínico i Provincial de Barcelona, Universidad de Barcelona, Barcelona, España.
No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / pathology
-
Adenocarcinoma / radiotherapy
-
Administration, Metronomic
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carboplatin / administration & dosage
-
Combined Modality Therapy
-
Epistaxis / etiology
-
Female
-
Humans
-
Middle Aged
-
Nasal Obstruction / etiology
-
Nasopharyngeal Neoplasms / drug therapy*
-
Nasopharyngeal Neoplasms / pathology
-
Nasopharyngeal Neoplasms / radiotherapy
-
Neoplasm Invasiveness
-
Tegafur / administration & dosage